Evonik Evonik

X

Find Linerixibat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Linerixibat
Also known as: 1345982-69-5, Gsk2330672, Gsk-2330672, Iinerixibat, Linerixibat [usan], Chembl2387408
Molecular Formula
C28H38N2O7S
Molecular Weight
546.7  g/mol
InChI Key
CZGVOBIGEBDYTP-VSGBNLITSA-N
FDA UNII
386012Z45S

GSK2330672 has been investigated for the treatment of Diabetes Mellitus, Type 2.
1 2D Structure

Linerixibat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-16,4-benzothiazepin-8-yl]methylamino]pentanedioic acid
2.1.2 InChI
InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1
2.1.3 InChI Key
CZGVOBIGEBDYTP-VSGBNLITSA-N
2.1.4 Canonical SMILES
CCCCC1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)C(N1)C3=CC=CC=C3)CC
2.1.5 Isomeric SMILES
CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC
2.2 Other Identifiers
2.2.1 UNII
386012Z45S
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-((((3r,5r)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic Acid

2. Gsk2330672

2.3.2 Depositor-Supplied Synonyms

1. 1345982-69-5

2. Gsk2330672

3. Gsk-2330672

4. Iinerixibat

5. Linerixibat [usan]

6. Chembl2387408

7. Linerixibat (usan)

8. 386012z45s

9. 3-[[(3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2h-1lambda6,4-benzothiazepin-8-yl]methylamino]pentanedioic Acid

10. Pentanedioic Acid, 3-((((3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl)methyl)amino)-

11. Unii-386012z45s

12. Pentanedioic Acid, 3-[[[(3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl]methyl]amino]-

13. Linerixibat [inn]

14. Linerixibat [jan]

15. Linerixibat [who-dd]

16. Schembl2586025

17. Bcp17155

18. Ex-a1180

19. Vdc98269

20. Bdbm50434858

21. Mfcd28386358

22. Who 10729

23. Zinc96270862

24. Cs-5447

25. Db11729

26. Gsk 2330672

27. Ac-36158

28. As-35059

29. Hy-16643

30. D11539

31. Gsk 2330672;gsk-2330672

32. J-690137

33. Q27256749

34. 3-((((3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepin-8-yl)methyl)amino)pentanedioic Acid

35. 3-((((3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro- 1h-1.lambda.6,4-benzothiazepin-8-yl)methyl)amino)pentanedioic Acid

36. 3-({[(3r,5r)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic Acid

37. 3-[[[(3r,5r)-3-bu-3-et-2,3,4,5-tetrahydro-7-ome-1,1-dioxido-5-ph-1,4-benzothiazepin-8-yl]methyl]amino]pentanedioic Acid

38. 3-[[[(3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl]methyl]amino]pentanedioic Acid

2.4 Create Date
2011-11-21
3 Chemical and Physical Properties
Molecular Weight 546.7 g/mol
Molecular Formula C28H38N2O7S
XLogP3-1.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count13
Exact Mass546.23997273 g/mol
Monoisotopic Mass546.23997273 g/mol
Topological Polar Surface Area150 Ų
Heavy Atom Count38
Formal Charge0
Complexity870
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of primary biliary cholangitis


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY